Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Mitomycin C in Glaucoma Filtering Surgery
NCT00468429Phase 4Unknown
- Sponsor
- Grewal Eye Institute
- Start
- May 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bevacizumab in Glaucoma (2 arms), sponsored by Grewal Eye Institute. Primary endpoints: Intraocular Pressure Reduction at 6 months and Bleb Morphology Grading at 6 months. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00468429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468429.